Evidence map›Paper›PMID 41683299›Full record

ArticleNutrients2026

The Effects of Vitamin D Replacement with a High-Dose Treat-to-Goal Strategy.

Rodis D Paparodis, Nikolaos Angelopoulos, Sarantis Livadas, Evangelos Karvounis, Dimitrios Askitis, Juan C Jaume, Dimitrios T Papadimitriou

Abstract read
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rodis D PaparodisHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0003-2804-0859
Nikolaos AngelopoulosHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0002-8901-7161
Sarantis LivadasHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0001-9594-1521
Evangelos KarvounisHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0003-2308-0245
Dimitrios AskitisHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0003-3844-8348
Juan C JaumeDepartment of Medicine, Edward Hines Jr. VA Hospital, Hines, IL 60141, USA.ORCID 0000-0002-2723-331X
Dimitrios T PapadimitriouHellenic Endocrine Network, 10563 Athens, Greece.ORCID 0000-0002-6083-3560

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVitamin D deficiency [25(OH)D < 30 ng/mL] is widely prevalent globally and the efforts to tackle it have been rather unsuccessful to date. Despite different cutoffs used to define it, many clinicians adhere to the 2011 Endocrine Society definition. We present a special treat-to-target protocol aiming to restore and maintain vitamin D sufficiency.

methodsWe reviewed the efficacy and safety of our vitamin D supplementation protocol over 5 years, and compared it to a group of patients who self-reported never taking vitamin D supplements. We recorded the baseline, 2-month, and annual 25(OH)D (D) measurements, along with subjects' age, sex, BMI, history of osteoporosis, nephrolithiasis, nephrocalcinosis, and renal colics. According to our supplementation protocol, replenishment of vitamin D involves cholecalciferol dosing in two steps: a loading dose (LD) for 2 months and a maintenance dose (MD) thereafter. Please refer to the main text for loading and maintenance dose titration.

resultsOf 8329 cases with vitamin D measurements, 2248 had adequate follow up data of 3524.5 patient-years and were included in the study: a total of 1575 intervention subjects and 673 controls, with an average follow-up of 18.8 months. Baseline vitamin D concentrations of 22.6 ng/mL (controls) did not change significantly (2 months: 22.2; 1 year: 21.7; 2 years: 22.0; 3 years: 23.8; 4 years: 21.8; and 5 years: 22.1 ng/mL), while concentrations of 21.9 ng/mL (intervention group) reached and remained 40 ng/mL (2 months: 41.0; 1 year: 39.4; 2 years: 39.0; 3 years: 39.3; 4 years: 40.4; and 5 years: 39.4 ng/mL). Vitamin D adequacy was achieved in 91.6% of patients in the intervention arm compared to only 16.9% in controls (

conclusionsOur intervention protocol appears highly efficient in achieving and maintaining vitamin D adequacy over 5 years, with no increase in adverse events compared with controls, presenting it as an effective long-term strategy.

Indexed as

CholecalciferolDietary SupplementsVitamin DVitamin D DeficiencyAdultAgedFemaleHumansMaleMiddle AgedTreatment OutcomeCholecalciferolVitamin Dhigh-dose supplementationvitamin D deficiencyvitamin D replacement

Identifiers

PMID41683299
PMCPMC12899947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.